FDA approves new drug brand for treatment of pediatric NDO patients
Today, the U.S. Food and Drug Administration approved a new brand for Myrbetriq (extended mirabegron tablets) and Myrbetriq Granules (mirabegron for oral contraceptives with extended release) to tr…
